=
 
 
 
 

Summary:
Musaed Alkholief earned his Ph.D. in 2015 from Massachusetts College of Pharmacy and Health Sciences University, USA. Following his return to Saudi Arabia, he was appointed as an Assistant Professor at the College of Pharmacy, King Saud University. Since then, he has been involved in teaching multiple courses for undergraduate and graduate students, while heading the Nanobiotechnology research unit that carries out research in multiple areas, including his area of interest, cancer drug delivery and drug targeting. On the administrative level, Dr. Alkholief was actively involved early on in many committees and councils in the College of Pharmacy, which has lead King Saud University to appoint him as the Assistant Vice-Rector for Planning and Development in February 2017, besides his aforementioned academic and research activities. Moving forward, Dr. Alkholief continues to expand his knowledge base in the pharma and biotech industry.

Academic Degrees:

• 2010 – 2015

Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences, Massachusetts College of Pharmacy and Health Sciences University, Boston, MA, USA.

• 2002 – 2008

Bachelor of Pharmaceutical Sciences, King Saud University, Riyadh, Saudi Arabia
 
Academic Positions:

• Jul 2015 – to date

Assistant Professor, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia.

• Jul 2008 – Aug 2009

Teaching Assistant, Department of Pharmaceutics, King Saud University, Riyadh, Saudi Arabia.
 
Professional Experience:

• Mar 2018 – to date

Certified Project Management Professional (PMP) by the project management institute.
 
Continuing Professional Education and Development:
- 5-Day Mini MBA for the Pharma and Biotech Industry (Management Center Europe).
- Vaccines Bioprocess Development and Commercialization (University College London).
- Critical Scientific and Regulatory Considerations of Biosimilars (King Saud University).
- Biosimilars: National and International Perspectives (King Saud University).
- Antibodies: Sequence, Structure and Designing Therapeutics (University College London).
- Project management professional PMP training program (PMI and King Saud University).
- First Saudi Drug Quality Symposium (Alfaisal University and Novartis).
- Essentials for Effective Peer Review of Teaching (King Saud University).
- Fundamentals of Student Assessment system (King Saud University).
- Biosafety and Bloodborne Pathogen Refresher for Laboratory Personnel (Northeastern University).
- Radiation Safety Initial Worker Online Training (Northeastern University).
- Chemical Hygiene Training - Lab Safety and Hazardous Waste Management (MCPHS University).
 
Courses Taught:
- PHT 210: Pharmaceutical Calculations (PharmD program).
- PHT 414: Biopharmaceutics (B. Pharm program).
- PHT 417: Biopharmaceutics and Pharmacokinetics (PharmD program).
- PHT 426: Pharmaceutical Biotechnology (PharmD program).
- PHT 539: Advanced Biopharmaceutics (MS. program).
- PHT 612: Selected Topics in Drug Delivery I (PhD program).
- PHT 624: Selected Topics in Drug Delivery II (PhD program).

• :

 
- Speaker: Collaborative Meeting for the Integration of Roles and Responsibilities between Education Excellence Commission and the Universities, Riyadh, Saudi Arabia 2017.
 
- Speaker: Biosimilar Cell Line Development, First GCC Stakeholder Meeting on Approval Process, Interchangeability/Substitution and Safety of Biosimilars, Riyadh, Saudi Arabia, 2017
 
- Speaker: Applications of Nanotechnology in Cancer, King Abdullah Institute for Nanotechnology – Nano Club and King Saud University, 2017.
 

Administrative Positions:

•  Feb 2018 – to date

Acting Director of the Statistics and Information Department.

• Feb 2017 – to date

Assistant Vice-Rector for Planning and Development, King Saud University, Riyadh, Saudi Arabia.
- The Vice-Rectorate for Planning and Development encompasses the following entities: the deanship of development and quality, the deanship of skills development, KSU training center, KSU press center, documents center, statistics and information department, risk management department, and community relations office.

- Direct oversight over the activities of the Vice-Rector’s office and supervising the plans and achievements of the aforementioned entities.
- As the Vice-Rectorate for Planning and development is the head of key units in planning-quality-information, responsibilities includes, but not limited to:

• Offering guidance on institutional leadership in all planning-quality-information matters, creating services, and supporting value to all academic and administrative units institution wide.
•  Providing direct oversight on all policy matters and supervising the planning-quality-information functional areas within its institutional jurisdiction to key operational units under the direct supervision of the vice-rectorate.
• Ensuring efficient and effective performance monitoring, measurement and management of the main planning-quality-information functional areas as planned, executed and managed for performance on the ITQAN 2020 system platform by the units under the vice-rectorate supervision.

Councils and Committees membership:
- Registration Committee of companies and factories of veterinary medicines and their products – Saudi Food and Drug Authority (May 2018 – to date).
-  The coordinating committee between the vice-rectorate for planning and development and the vice-rectorate for educational and academic affairs, King Saud University (Feb 2018 – to date).
- King Saud University representative at the second workshop for discussing the new and updated standards for institutional and program accreditation, Education Excellence Commission (Dec 2017).
- Strategic plan steering committee, College of Pharmacy, King Saud University (Oct 2017 – to date).
- Curriculum development committee, College of Pharmacy, King Saud University (Oct 2017 – to date).
- Health colleges students’ interview committee, King Saud University (July 2017).
- King Saud University representative in deliberating the Saudi Arabian Qualifications’ Framework Project with the Education Excellence Commission (Apr 2017)
-Vice-rectorate for planning and development representative in King Saud University’s committee for the preparation of administrative policies and procedures manual (Mar 2017 – to date).
- Pharmacy College Council, College of Pharmacy, King Saud University (Dec 2016 – to date).
- Pharmaceutics Department Council, College of Pharmacy, King Saud University (Sep 2015 – to date).
- Assessment committee, College of Pharmacy, King Saud University (Sep 2015 – Feb 2017)
- Pharmacy Education Unit Committee, College of Pharmacy, King Saud University (Dec 2015 – Feb 2017)
- Exams Committee, College of Pharmacy, King Saud University, (Sep 2015 – Sep 2016)
- Pharmaceutics department representative in quality and accreditation committee. College of Pharmacy, King Saud University (Sep 2015 – Feb 2017).
- Pharmaceutics Department Employment and Human Resources committee, College of Pharmacy, King Saud University (Sep 2015 – to date).
- Pharmaceutics department Graduate Program Research Proposal Investigation committee, College of Pharmacy, King Saud University (Sep 2015 – to date).       

Positions:

• Sep 2017 – to date

Director of the Nanobiotechnology Research Unit, College of Pharmacy, King Saud University.

• May 2016 – Sep 2017

Deputy Director of the Nanobiotechnology Research Unit, College of Pharmacy, King Saud University.

• Apr 2016 – to date

Associate Editor, Saudi Pharmaceutical Journal, Saudi Arabia.
 
 
Publications and Abstracts:

• Sultan Alshehri, Musaed Alkholief, Mohammad Altamimi, Kazi Mohsin, Ehab Elzayat, Ibrahim Alsarra, Mohamed Ibrahim, Fars Alanazi, Faiyaz Shakeel, Osaid Almeanazel. Formulation of solid dispersions of apigenin using different techniques: In vitro and pharmacokinetic evaluation. (Submitted)

• Faiyaz Shakeel, Mohd Abul Kalam, Ph.D.; Sultan Alshehri, Ph.D.; Aws Alshamsan, Ph.D.; Musaed  Alkholief, Ph.D.; Raisuddin Ali, Ph.D.; Solubility, Hansen solubility parameters and thermodynamic energies of gemfibrozil particles in different pharmaceutically used solvents. (Submitted)

• Pretreatment With Risperidone Ameliorates Systemic LPS-Induced Oxidative Stress in the Cortex and Hippocampus. Al-Amin, M. M., Choudhury, M. F. R., Chowdhury, A. S., Chowdhury, T. R., Jain, P., Kazi, M., Alkholief, M., Alshehri, S. M., Reza, H. M. Frontiers in neuroscience 2018 Jun 8;12:384.

• Ceftolozane-tazobactam for the treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a patient receiving intermittent hemodialysis. Alessa MA, Almangour TA, Alhossan A, Alkholief MA, Alhokail M, Tabb DE  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 75:e184-e188.

• Alshehri S, Shakeel F, Ibrahim M, Elzayat E, Altamimi M, Alkholief M, et al. Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. PLoS One. 2017;12(7):e0182011.

• Talal Nahar-Alshammari, Mohd Abul Kalam, Musaed Alkholief, and Aws Alshamsan. Development and characterization of liposomal delivery system of Metformin and Reserpine. 7th College of Pharmacy Research Day (7th CPRD), 2017.

• Shweta A. Raina, Aalok Shah, Xin Wang, Musaed Alkholief, Samuel Gatley, Kai-Tak Wan,  and Robert B. Campbell. Characterizing functional properties of mucin glycosylation: Differential cytotoxicity, intracellular drug uptake, and mechanical forces delaying drug entry. (submitted)

• Alkholief, M. and R. B. Campbell "Investigating the role of mucin in the delivery of nanoparticles to cellular models of human cancer disease: an in vitro study." Nanomedicine: Nanotechnology, Biology and Medicine. Volume 12, Issue 5, 1291 - 1302.

• Alkholief M, Campbell R. An Evaluation of the Role of Mucin in Nano Drug Delivery II. First Joint NanoWorcester/AVS-New England Spring meeting at WPI. Worcester, MA 2015.
• Shaohua Cheng, William Crall, Bryan Nguyen, Charles Dang, Musaed Alkholief, Robert Campbell. Development of Ceramide Liposomes for Tumor Interstitial and Vascular Drug Targeting. American Association of Cancer Research (AACR) annual meeting. San Diego, CA 2014.

• Acheampong S, Dang C, Huynh H, Nguyen R, Truong P, Alkholief M, Campbell R Analysis of Cationic Ceramide Liposomes in Anticancer Drug Therapy: An in vitro study. Second Annual SOP-W/M Research Day. Worcester, MA 2013

• Alkholief M, Campbell R. An Evaluation of the Role of Mucin in Nano Drug Delivery I. American Association of Cancer Research (AACR) annual meeting. Washington, DC 2013.

• Alkholief M, Djazayeri S, Price K, Campbell R. An Evaluation of Mucin Expression in Cancerous Tissues. First Annual SOP-W/M Research Day. Worcester, MA 2012.

• Alkholief M, Abdulghani A, Zeineldin R. Intracellular fate of carbon nanotubes targeting specific receptors on ovarian cancer cells. Nano in Cancer – American Association of Cancer Research (AACR) special conference. Miami, FL 2011.